CASI Pharma (CASI) Reports Q2 Loss of $0.06/Share

CASI Pharma (NASDAQ: CASI) reported Q2 EPS of ($0.06), versus ($0.06) reported last year. Revenue for the quarter came in at $24 thousand, versus $0 reported last year.

For earnings history and earnings-related data on CASI Pharma (CASI) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• Morgan Stanley more than doubles Lenovo price target on AI-driven growth
• UBS Reiterates Neutral Rating on Buckle, Inc. (BKE)